Latest news
OITBs contributing to an open and connected innovation ecosystem
Due to long reimbursement processes, patient access to innovative high-risk medical devices can take very long. In addition, the new EU Medical Devices Regulation (2017/745) is imposing stricter requi...
TBMED at OITB workshop
We are happy to announce that Andrea Haiek from TBMED coordinator CIDETEC will join the OITB workshop at IndTech 2020 (Conference on Industrial Technologies) representing the TBMED project and its OIT...
Supporting med-tech companies to win the innovation race: New TBMED video crosses the finish line
Medical device development, from conception to timely release to market, can be expensive and risky. This is particularly true for high-risk medical devices affected by the EU’s current Regulation 201...
TBMED tutorial set now complete!
Developing a medical device (MD) is a complex and often challenging process. This is particularly true for high-risk medical devices affected by the EU’s current regulation 2017/745. Providing a full...
go.Med – Open Innovation Test Bed for medical devices
In preparation of the upcoming launch of our Open Innovation Test Bed (OITB) go.Med by the end of 2022 we have created a brand-new subpage on our TBMED website explaining to medical device developers...
5th Progress Meeting – Facing challenges on the way to launch the OITB
May it be that the second half of a project is always running faster than the first? It seemed like yesterday that we had our last Progress Meeting although half a year had past before the entire TBME...
Regulation (EU) 2017/745 on Medical Devices applicable since May 26, 2021
While Regulation (EU) 2017/745 came into force already on 25 May 2017, originally approved medical devices had a transition time of three years to meet new requirements. Since May 26, 2021, the new re...
New tutorial series launched by TBMED
Developing a medical device (MD) is a complex and often challenging process. This is particularly true for high-risk medical devices affected by the EU’s current regulation 2017/745.
The process of...
TBMED collaboration with EU project HOTZYMES
Dr Raluca Fratila from TBMED partner UNIZAR gave a talk about the use of magnetic heating for therapy and the TBMED project in the Workshop “Designing MNPs for nanoactuation based on magnetic heating...
Bringing a product to the market - A case study experience by Siltiss
Glycobone – an injectable ready-to-use polysaccharide-based scaffold combined with hydroxyapatite tailored for oral bone defect reconstruction – is one of the use cases developed in TBMED by SILAB’s s...
When magentic nanoparticles dance
What happens when artists meet scientists? UNIZAR team members Lucía Gutiérrez and Raluca Fratila wanted to know and joined the “NanoAsalto” project, which uses art as a vehicle to communicate science...
TBMED 4th Progress Meeting to kick-off the second half of the project
TBMED started the new year and the second half of the project’s duration with its 4th Progress Meeting held virtually on January 27-28, 2021. Despite working under the persistent constraints of the Co...
TBMED Open Call: Support for CPoC or clinical investigations
TBMED launches an Open Call with the objective of providing support to developers which aim to perform a Clinical Proof of Concept (CPoC) or clinical investigation with an innovative high risk medical...
MedTech OITBs join forces in the fight against COVID-19
Small and Medium-sized Enterprises (SMEs) as well as other businesses were put at high risk by the economic slowdown caused by the COVID-19 pandemic across Europe. Consequently, the three EU funded Me...
Successful completion of first 18 project months
It is amazing how time flies: the first 18 months of our TBMED project are already over. The end of our first project period came along with our first review meeting. Contrary to our plans at the begi...
TBMED makes quite some noise in Zaragoza
Within the scope of their 2nd Progress Meeting, the TBMED continued its series of so-called Open Sessions in Zaragoza, Spain on January 15, 2020. Among the companies and clusters joining the session a...
Starting the year with full force – TBMED 2nd Progress Meeting in Zaragoza
While the new year is still young, the TBMED consortium is already working at full force and came together for the project’s 2nd Progress Meeting and an Open Session in Zaragoza, Spain on January 15-1...
Successful „Go-to-Market“ Strategies: TBMED to be Presented on Annual Stakeholder Event of the European IP Helpdesk
Iraida Loinaz will join the team of the European IP Helpdesk in Brussels on November 26, 2019 to present TBMED during the initiative’s annual stakeholder meeting. The European IP Helpdesk is a servi...
TBMED is now on Twitter!
We are happy to announce that TBMED has joined the Twitter community. You can now follow us on @TBMED_EU.
We are looking forward to exchanging our ideas with you and keep you informed about the la...
TBMED on its way to build an Open Innovation Test Bed
Half a year into the project, the TBMED consortium met in Paris, France for their 1st Progress Meeting on July 9-10, 2019. The meeting was hosted by Didier Letourneur and his team from TBMED partner I...
TBMED at EuroNanoForum and NME 2019
June was a busy month for TBMED as the project was presented for the first time after its start at two major European events.
At EuroNanoForum on June 12-14, 2019, TBMED was part of the “Safe by D...
Support for European Med-Tech Companies
The new EU research project TBMED aims to support European med-tech companies in global competition by reducing the time-to-market of high-risk medical devices (MD). An Open Innovation test bed for th...
Upcoming events
IndTech 2022
June 28, 2022 — June 30, 2022
Grenoble, France